Home › Urothelial (Transitional Cell) Carcinoma
Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma na nagre-recruit sa U.S.
72 pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Nashville, TN23 pag-aaral
- New York City, NY22 pag-aaral
- Dallas, TX18 pag-aaral
- Edison, NJ18 pag-aaral
- Houston, TX18 pag-aaral
- Los Angeles, CA17 pag-aaral
- Queens, NY15 pag-aaral
- Chicago, IL14 pag-aaral
- Arlington, VA12 pag-aaral
- San Antonio, TX11 pag-aaral
- Boston, MA11 pag-aaral
- Austin, TX10 pag-aaral
- Orange, CA10 pag-aaral
- Philadelphia, PA9 pag-aaral
- Washington, DC9 pag-aaral
- Columbus, OH9 pag-aaral
- Baldwin Park, CA9 pag-aaral
- Atlanta, GA8 pag-aaral
- Cleveland, OH8 pag-aaral
- Jacksonville, FL8 pag-aaral
- Durham, NC8 pag-aaral
- Seattle, WA8 pag-aaral
- Irvine, CA8 pag-aaral
- Orlando, FL7 pag-aaral
- Omaha, NE7 pag-aaral
- Portland, OR7 pag-aaral
- San Francisco, CA7 pag-aaral
- St. Louis, MO7 pag-aaral
- New Rochelle, NY7 pag-aaral
- Staten Island, NY7 pag-aaral
- Greenburgh, NY7 pag-aaral
- Milwaukee, WI6 pag-aaral
- Denver, CO6 pag-aaral
- Phoenix, AZ6 pag-aaral
- New Haven, CT6 pag-aaral
- Detroit, MI6 pag-aaral
- Gainesville, FL6 pag-aaral
- Oklahoma City, OK6 pag-aaral
- Charlotte, NC6 pag-aaral
- Ann Arbor, MI6 pag-aaral
Ayos sa estado
- Alabama4 pag-aaral
- Arizona10 pag-aaral
- Arkansas5 pag-aaral
- California33 pag-aaral
- Colorado10 pag-aaral
- Connecticut7 pag-aaral
- District of Columbia7 pag-aaral
- Florida22 pag-aaral
- Georgia11 pag-aaral
- Idaho4 pag-aaral
- Illinois21 pag-aaral
- Indiana7 pag-aaral
- Iowa7 pag-aaral
- Kentucky4 pag-aaral
- Louisiana4 pag-aaral
- Maryland8 pag-aaral
- Massachusetts15 pag-aaral
- Michigan15 pag-aaral
- Minnesota7 pag-aaral
- Missouri10 pag-aaral
- Montana3 pag-aaral
- Nebraska7 pag-aaral
- Nevada3 pag-aaral
- New Jersey21 pag-aaral
- New York29 pag-aaral
- North Carolina15 pag-aaral
- Ohio17 pag-aaral
- Oklahoma8 pag-aaral
- Oregon8 pag-aaral
- Pennsylvania15 pag-aaral
- South Carolina8 pag-aaral
- South Dakota3 pag-aaral
- Tennessee25 pag-aaral
- Texas38 pag-aaral
- Utah6 pag-aaral
- Virginia21 pag-aaral
- Washington12 pag-aaral
- Wisconsin9 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06270706Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06524544A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090499Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Nagre-recruit
Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06262516The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07285044Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05874921DBC-664 in Adult Patients With Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07705035A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05562830Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06439836Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT05239624Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07043972A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07532902GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04977453A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07815665A Study of GEN1106 in Participants With Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07416123A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06040762Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.